Cardiovascular magnetic resonance

Selvanayagam JB, Porto I, Channon K, et al, Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury insights from cardiovascular magnetic resonance imaging, Circulation 2005 ... [Pg.168]

Kim RJ, Manning WJ. Viability assessment by delayed enhancement cardiovascular magnetic resonance will low-dose dobutamine dull the shine Circulation 2004 ... [Pg.449]

Table 5.4 Proportions of agreement between electrocardiographic patterns and contrast-enhanced cardiovascular magnetic resonance for the different myocardial infarction locations and their 95% confidence interval. (Bayes de Luna 2006a)...

The block of middle fibers of LBB has to be included in the differential diagnosis of prominent R wave in VI (see Table 5.5). To make this diagnosis in patients with ischemic heart disease the involvement (ischaemia or necrosis) of lateral wall has to be rule out (coronary angiography and/or cardiovascular magnetic resonance-CMR-) (Fig. 5.64). In the case of lateral MI a positive T wave in VI is seen, and in case of block of middle fibers the T wave in VI is usually negative. [Pg.193]

Bayes de Luna A, Cino JM, Pujadas S et al. Concordance of electrocardiographic patterns and healed myocardial infarction location detected by cardiovascular magnetic resonance. Am J Cardiol 2006a 97 443. [Pg.311]

Bayes de Luna A, Cino J, Kotzeva A et al. New ECG criteria of inferolateral myocardial infarction assessed by contrast enhanced-cardiovascular magnetic resonance based on the morphology of QRS in VI. Eur Heart J Supl 2006b 27 871. Abstract. [Pg.311]

Cino JM, Pujadas S, Carreras F et al. Utility of contrast-enhanced cardiovascular magnetic resonance (CE-CMR) to assess how likely is an infarct to produce a typical ECG pattern. J Cardiovasc Magn Reson 2006 8 335. [Pg.312]

Mahrholdt H, Wagner A, Judd RM, Sechtem U. Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J 2002 23 602. [Pg.317]

Moon JC, De Arenaza DP, Elkington AG, Taneja AK, John AS, Wang D. The pathologic basis of Q-wave and non-Q-wave myocardial infarction a cardiovascular magnetic resonance study. J Am Coll Cardiol 2004 44 554. [Pg.318]

Pons-Llad6 G, Carreras F. Atlas of Practical Applications of Cardiovascular Magnetic Resonance. New York Springer, 2005. [Pg.320]

Selvanayagam J, Kardos A, Nicolson D et al. Anteroseptal or apical myocardial infarction a controversy addressed using delayed enhancement cardiovascular magnetic resonance imaging. J Cardiovasc Magn Reson 2004 6 653. [Pg.321]

Ganz W, Serafini A, Lemer D, et al. Cardiovascular magnetic resonance imaging goes beyond anatomy. Crit Rev Diagn Imaging 1995 36 479-503. [Pg.169]

Blyth KG, Groenning BA, Martin TN, et al. Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 2005 26 1993-9. [Pg.161]

M. Andreas, A. I. Schmid, M. Keilani, D. Doberer, J. Bartko, R. Crevenna, E. Moser and M. Wolzt, Journal of Cardiovascular Magnetic Resonance, 2011,13. [Pg.551]

Lopez JE, Yeo K, Caputo G, Buonocore M, Schaefer S. Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance. J Car-diovasc Magn Reson 2009 11 46. [Pg.12]

The authors of a report of three cases of myocarditis associated with clozapine claimed that, while the gold standard for the diagnosis of myocarditis is perceived to be by myocardial biopsy, cardiovascular magnetic resonance has also proved... [Pg.63]

Ariyarajah V, Shaikh N, Garber PJ, Kirkpatrick I, McGregor R, Jassal DS. Cardiovascular magnetic resonance in mild to moderate clozapine-induced... [Pg.80]

Imaging with PET or contrast enhanced cardiovascular magnetic resonance can identify areas of LV scar. The placement of the LV lead at areas of LV scarring will show no response to CRT and can lead to worsening of heart failure due to unopposed RV pacing (75) or worsening of ventricular tachycardia (76). Bleeker et al. showed that patients with transmural scar in the posterolateral LV (as assessed by MRI) did not show clinical or echocardiographic response with CRT (77). [Pg.444]

Cheng AS etal. (2007) Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease a comparison with 1.5-tesla J Am Coll Cardiol 49 2440-2449... [Pg.282]

Gelfand EV et al. (2006) Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson 8 503 507... [Pg.282]

Moon JC etal. (2003) Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 1561-1567 Nagel E et al. (2003) Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 108 432-437 Nikolaou K et al. (2004) Assessment of myocardial infarctions using multidetector-row computed tomography. J Comput Assist Tomogr 28 286 292... [Pg.283]

Vogelsberg H et al. (2008) Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 51 1022-1030... [Pg.284]

Petersen SE, Kardos A, Neubauer S. Subendocardial and papillary muscle involvement in a patient with Churg-Strauss s3mdrome, detected by contrast enhanced cardiovascular magnetic resonance. Heart 2005 91(l) e9. [Pg.654]

Evanochko WT and Pohost GM (1993) H NMR studies of the cardiovascular system. In Schaefer S and Balaban RS (eds) Cardiovascular Magnetic Resonance Spectroscopy, pp 185-193. Norwell, MA Kluwer Academic. [Pg.607]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...